info@biomedres.us   +1 (502) 904-2126   One Westbrook Corporate Center, Suite 300, Westchester, IL 60154, USA   Site Map
ISSN: 2574 -1241

Impact Factor : 0.548

  Submit Manuscript

Short CommunicationOpen Access

Study Regarding the Inhibition of Acetylcholinesterase by Isopropyl 4-Nitrophenyl Methylphosphonate Volume 14 - Issue 2

Tudor V Tiganescu1, Raluca E Ginghina*2, Nicoleta Grigoriu*2, Mihaela Muresan2, Constantin N Toader2 and Bogdan Patrinichi3

  • 1Military Equipment and Technologies Research Agency, Romania
  • 2Scientific Research Center for CBRN Defense and Ecology, Romania
  • 3Military Medical Research Institute, Romania

Received: February 04, 2019;   Published: February 11, 2019

*Corresponding author: Nicoleta Grigoriu, Scientific Research Center for CBRN Defense and Ecology, Romania

Raluca E Ginghina, Scientific Research Center for CBRN Defense end Ecology, Romania

DOI: 10.26717/BJSTR.2019.14.002539

Abstract PDF

Also view in:

abstract

At present, many scientific institutions around the world are interested in the synthesis and improvement of new antidotes against Chemical Warfare Agents (CWAs), especially nerve agents, because of the continuous threat of the nerve agent misuse by terrorists. Few studies have been published concerning the reactivity of CWAs due to the danger of conducting such experiments, the limited laboratory supply of CWAs and the classified nature of the materials. The inherent toxicity and limited laboratory supply of CWAs has led to the development and study of safer compounds that simulate the chemistry and the reactivity of CWAs. Antidotes as Acetylcholinesterase (AChE) reactivators containing oxime groups have been demonstrated to be effective for the breakdown of nerve agents and/or their simulants. The study proposes a simulant for sarin, for experimental.

Keywords: Isopropyl 4-Nitrophenyl Methylphosphonate; Arin; Chemical Warfare Agents; Ache Inhibition

Introduction

Isopropyl 4-Nitrophenyl Methylphosphonate (NIMP) [1,2], a sarin simulant, was synthesized for testing the AChE inhibition capacity, in order to find it as suitable chemical simulant [3] for sarin (Figures 1 & 2). In vivo pharmacotoxicological experimental study of the above presented chemical compound was performed in order to determine its LD50 value, the degree of cholinesterase inhibition lethal doses appropriate, and the oxime assisted protective ration case of poisoning. To determine the LD50 and index protection defined as the ratio of LD50 the lot poisoning CWA simulant and treated and LD50 the lot intoxicated and untreated, there were used laboratory animals (rats Wistar) distributed in homogenous groups (intoxicated, treated and batch control). Monitoring of animals during the experiment was to record the moment signs of intoxication, mortality recording 60 minutes, 24 hours after poisoning the lots intoxicated and intoxicated and treated, tracking and recording time appearance remission signs of intoxication lots intoxicated and treated. The AChE activity was measured by using the standardised bioanalytical method performed by Eyer & Woreck in 2001. The used specimen was rat heparinised blood collected by venous punction. A UV/VIS Perkin Elmer Spectrometer equipped with soft UV KinLab. Lambda 40 was used as measuring equipment. Experimental data statistical analysis was performed by using Student’s T test and One Way Anova test.

Figure 1: Structures of nerve agent (sarin) and the corresponding simulant (NIMP) used in the biological study.

biomedres-openaccess-journal-bjstr

Sarin

Isopropyl 4-nitrophenyl

C4H10FO2P

methylphosphonate

C10H14NO5P, MW 259

MW 140, [107-44-8]

Figure 2: NIMP general synthesis reaction.

biomedres-openaccess-journal-bjstr

Experimental Results

Inhibition of erythrocyte [4] AChE due to the studied compound three doses in the range of logarithmic progression of the points, showed a related to dose pharmacodynamic effect between 53% and 95%, values like those of the reference compound. NIMP doses in the range of LD50 (0.59, 0.47, and 0.31 mg/kg i.p.) leads to 95, 87, and 53% of AChE inhibition, comparable to the AChE inhibition values determined by the appropriate range LD50 of nerve agent correspondent, sarin. The experimental data are presented in the Figure 3. The calculated LD50 values by using our experimental data was 0.45 ± 0.002 mg/ kg i.p. (reference range 0.31 to 0.59 mg/kg i.p.) for NIMP. The regression equation and the correlation coefficient calculation results in NIMP LD50 are presented in the Figure 4. The determination of the protection ratio, linear regression and correlation coefficient are represented in Figure 5 and (Table 1).

Figure 3: Structures of nerve agent (sarin) and the corresponding simulant (NIMP) used in the biological study.

biomedres-openaccess-journal-bjstr

Figure 4: The regression equation and the correlation coefficient calculation results in NIMP LD50; X axislogarithmic values of doses administered 3 groups introduced in the experiment; Y axis- values of the probit corresponding to mortality percentage.

biomedres-openaccess-journal-bjstr

Figure 5: Highlighting experimental data of mortality in calculating the protective ratio in case of NIMP poisoning: 0.45 mg/kg NIMP LD50 doses administrated to the poisoned and untreated study group; 1.125 mg/kg NIMP LD50 doses administrated to the poisoned and oxime assisted study group.

biomedres-openaccess-journal-bjstr

Table 1: Highlighting experimental data of mortality in calculating the protective ratio in case of NIMP poisoning: 0.45 mg/kg NIMP LD50 doses administrated to the poisoned and untreated study group; 1.125 mg/kg NIMP LD50 doses administrated to the poisoned and oxime assisted study group.

biomedres-openaccess-journal-bjstr

Conclusion

The study showed that the percentage of inhibited AChE is comparable with the sarin one. Comparative analysis of LD50 values for NIMP and the correspondent nerve agent, showed lower intrinsec toxicity of the synthesized simulant. The protective ratio of antidote therapy (atropine, obidoxime) in the groups exposed to NIMP was I.P. = 2.5, value comparable with the sarin one. Also, the enzymatic AChE reactivation value was comparable to the relevant reference substance levels. Inhibiting activity of this nerve agent simulant is enough to mimic exposure to real agents, being present all the clinical signs typical of poisoning. As with aging sarin - related acetylcholinesterase, simulants show a slower rate of aging, prolonging survival time and allowing therapeutic window for reactivating oximes. Thus, it can be concluded that the compound studied shows similar pharmacodynamic effects and references due to lower intrinsic toxicity may be suitable as a simulant for research studies in the laboratory activities.

References

  1. Koskela, H, Grigoriu, N, Vanninen, P (2006) Screening and identification of organophosphorus compounds related to the chemical weapons convention with 1d and 2d nmr spectroscopy. Anal Chem 78(11): 3715 -3722.
  2. Y Ashani, RD Gupta, M Goldsmith, I Silman, JL Sussman, et al. (2010) Stereo-specific synthesis of analogs of nerve agents and their utilization for selection and characterization of paraoxonase catalytic scavengers. Chem Biol Interact 187(1-3): 362-369.
  3. EC Meek, HW Chambers, A Coban, KE Funck, RB Pringle, et al. (2012) Synthesis and in vitro and in vivo inhibition potencies of highly relevant nerve agent surrogates. Toxicol Sci 126(2): 525-533.
  4. H Ohta, T Ohmori, S Suzuki, H Ikegaya, K Sakurada, et al. (2006) New safe method for preparation of sarin-exposed human erythrocytes acetylcholinesterase using non-toxic and stable sarin analogue isopropyl p-nitrophenyl methylphosphonate and its application to evaluation of nerve agent antidotes. Pharm Res 23(12): 2827-2833.